BR0318443A - proteìnas solúveis em ácido de caseìna micelar - Google Patents

proteìnas solúveis em ácido de caseìna micelar

Info

Publication number
BR0318443A
BR0318443A BRPI0318443-9A BR0318443A BR0318443A BR 0318443 A BR0318443 A BR 0318443A BR 0318443 A BR0318443 A BR 0318443A BR 0318443 A BR0318443 A BR 0318443A
Authority
BR
Brazil
Prior art keywords
micellar casein
acid soluble
casein acid
soluble proteins
casein
Prior art date
Application number
BRPI0318443-9A
Other languages
English (en)
Inventor
Sandrine Gremlich
Lionel Bovetto
Catherine Mace
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of BR0318443A publication Critical patent/BR0318443A/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23J—PROTEIN COMPOSITIONS FOR FOODSTUFFS; WORKING-UP PROTEINS FOR FOODSTUFFS; PHOSPHATIDE COMPOSITIONS FOR FOODSTUFFS
    • A23J3/00—Working-up of proteins for foodstuffs
    • A23J3/04—Animal proteins
    • A23J3/08—Dairy proteins
    • A23J3/10—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/17—Amino acids, peptides or proteins
    • A23L33/19—Dairy proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones
    • A61P5/50—Drugs for disorders of the endocrine system of the pancreatic hormones for increasing or potentiating the activity of insulin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4732—Casein
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Mycology (AREA)
  • Endocrinology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Emergency Medicine (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

"PROTEìNAS SOLúVEIS EM áCIDO DE CASEìNA MICELAR". A presente invenção diz respeito a uma fração de leite obtenível por acidificação de caseína micelar e separação de caseína precipitada nomeada proteína solúvel em ácido de caseína micelar. Foi observado que a fração de leite e especialmente certas sub-frações deste são bioativas e promovem liberação de GLP-1 in vitro. Com base nestes resultados, proteína solúvel em ácido de caseína micelar pode ser útil no tratamento e na prevenção de diabetes do tipo ll, obesidade e pode também ser adicionada às fórmulas direcionadas a outros propósitos referindo ao trato gastrintestinal.
BRPI0318443-9A 2003-08-30 2003-08-30 proteìnas solúveis em ácido de caseìna micelar BR0318443A (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/EP2003/009669 WO2005021589A1 (en) 2003-08-30 2003-08-30 Acid soluble proteins from micellar casein

Publications (1)

Publication Number Publication Date
BR0318443A true BR0318443A (pt) 2006-08-01

Family

ID=34259107

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0318443-9A BR0318443A (pt) 2003-08-30 2003-08-30 proteìnas solúveis em ácido de caseìna micelar

Country Status (8)

Country Link
US (2) US7629442B2 (pt)
JP (1) JP2007525404A (pt)
CN (1) CN1860131A (pt)
AU (1) AU2003270130A1 (pt)
BR (1) BR0318443A (pt)
CA (1) CA2538507A1 (pt)
IL (1) IL173945A0 (pt)
WO (1) WO2005021589A1 (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101272803B (zh) * 2005-09-30 2012-11-21 森永乳业株式会社 胰高血糖素样肽-1分泌促进剂、胰高血糖素样肽-1分泌促进用饮食品、餐后血糖值上升抑制剂和餐后血糖值上升抑制用饮食品
CN102378632A (zh) 2009-04-03 2012-03-14 雀巢产品技术援助有限公司 对促进健康的追赶生长的改进
EP2286679A1 (en) * 2009-08-19 2011-02-23 Nestec S.A. Proteose peptone and lipase activity
EP2583562A1 (en) * 2011-10-21 2013-04-24 Nestec S.A. Use of whey protein micelles for infants at risk of obesity or diabetes
EP3590519A4 (en) 2017-03-03 2020-12-16 Morinaga Milk Industry Co., Ltd. GLP-1 SECRETAGOGUE AND COMPOSITION
BE1026671B1 (nl) * 2018-10-03 2020-05-05 Maeyer Stefan De Samenstelling van een speculaas bevattende melkhoudende drank en werkwijze om deze te bereiden
JP2024544249A (ja) * 2021-12-15 2024-11-28 フリースランドカンピーナ ネーデルランド ベスローテン フェンノートシャップ 免疫グロブリン富化乳画分

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2673374A1 (fr) * 1991-03-01 1992-09-04 Oreal Composition cosmetique contenant comme ingredient actif un peptide a activite opiouide.
NL1005037C2 (nl) 1997-01-17 1998-07-20 Nl Zuivelonderzoek Inst Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
GB9927603D0 (en) 1999-11-22 2000-01-19 Nestle Sa Use of a milk protein hydrolysate in the treatment of diabetes
DE60227922D1 (de) * 2002-05-27 2008-09-11 Nestec Sa Säurelösliche Proteine aus Casein-Micellen

Also Published As

Publication number Publication date
US7629442B2 (en) 2009-12-08
JP2007525404A (ja) 2007-09-06
US8686116B2 (en) 2014-04-01
CA2538507A1 (en) 2005-03-10
IL173945A0 (en) 2006-07-05
US20100111933A1 (en) 2010-05-06
US20060276632A1 (en) 2006-12-07
WO2005021589A1 (en) 2005-03-10
AU2003270130A1 (en) 2005-03-16
CN1860131A (zh) 2006-11-08

Similar Documents

Publication Publication Date Title
Tulipano et al. Characterisation of the potential of β-lactoglobulin and α-lactalbumin as sources of bioactive peptides affecting incretin function: In silico and in vitro comparative studies
ATE506957T1 (de) Prophylaktisches/therapeutisches mittel für neurodegenerative erkrankungen
MX2010006199A (es) Composicion nutricional enterica liquida basada en caseina micelar, densa en cuanto a proteina.
BR0209434A (pt) Peptìdeos antimicrobianos e composições
BR0010750A (pt) Peptìdeos insulinotrópicos de longa duração
CY1112115T1 (el) Παραγωγα φαινοξυοξικου οξεος χρησιμα για τη θεραπευτικη αντιμετωπιση ασθενειων του αναπνευστικου
BR0108713A (pt) Expressão hìbrida de proteìnas de neisseria
BRPI0508854A (pt) sais farmacêuticos de ácido-3-o-(3',3'-dimetilsuccinil) betulìnico
ATE464890T1 (de) Eine pharmazeutische zusammensetzung zur behandlung von pathologien, die durch die allgemeine immunantwort verursacht werden
RU2007139808A (ru) Способ улучшения обучаемости и памяти у млекопитающих
SE0002202D0 (sv) New peptides
DK1095061T3 (da) Peptider baseret på sekvensen af humant lactoferring og deres anvendelse
BRPI0415872A (pt) ácidos nucleìcos ligando especificamente à grelina bioativa
CY1117759T1 (el) Ενα καινουργιο φαρμακευτικο παρασκευασμα για την προ-εκλαμψια
BR0308860A (pt) Fator viii modificado
BRPI0515857A (pt) conjugados do fator-i de crescimento semelhante à insulina ( igf-i ) e polietileno glicol
BR0306838A (pt) Peptìdeo não-nativo, ácido nucléico isolado, composição farmacêutica e kit para prevenção ou tratamento de uma doença modulada por crf2r
ID27818A (id) Metode untuk menyediakan glutamin
BR0308713A (pt) Co-esférula de dha e alecrim, e métodos de uso
ATE447612T1 (de) Fluoreszenzproteine
BR0009472A (pt) Antagonistas de lhrh com propriedades desolubilidade aperfeiçoadas
ES2422081T3 (es) Péptido Ser-Ser-Ser-Arg y sus utilizaciones medicinales
DE60227922D1 (de) Säurelösliche Proteine aus Casein-Micellen
BR0315055A (pt) Diamidas de ácido pirimidin-4,6-dicarboxìilco para a inibição seletiva de colagenases
ATE358992T1 (de) Enteralpräparat zur vorbeugung gegen bzw. behandlung von sepsis

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE A 3A E 7A A NUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: REFERENTE AO DESPACHO 8.6 PUBLICADO NA RPI 2082 DE 30/11/2010.

B15K Others concerning applications: alteration of classification

Ipc: A23J 3/10 (2006.01), A23L 33/19 (2016.01), C07K 14